Exposure response (ER) analysis for efficacy and safety of mirvetuximab soravtansine (MIRV) in patients with folate receptor a (FR a)-positive cancer Meeting Abstract
| Authors: | Matulonis, U. A.; Moore, K. N.; Lorusso, D.; Oaknin, A.; Pignata, S.; Denys, H.; Colombo, N.; Van Gorp, T.; Konner, J.; Romeo Marin, M.; Harter, P.; Murphy, C.; Tu, Y.; Zhu, F.; Esteves, B.; Method, M.; Birrer, M. J.; Coleman, R. L.; O'Malley, D. |
| Abstract Title: | Exposure response (ER) analysis for efficacy and safety of mirvetuximab soravtansine (MIRV) in patients with folate receptor a (FR a)-positive cancer |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S817 |
| Language: | English |
| ACCESSION: | WOS:000866211600584 |
| DOI: | 10.1016/j.annonc.2022.07.720 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 592P -- Source: Wos |
